January 12, 2021 Medtech deal-making stands firm in difficult times It takes more than a pandemic to stop medical device companies merging.
July 09, 2020 Medical device mergers on pause 2019 was an average year for medtech M&A. 2020, not so much.
July 08, 2020 Smaller device makers put in a muted performance Mid- and small-cap medtechs find themselves at the mercy of government responses to the Covid-19 pandemic.
June 23, 2020 Invitae ends medtech merger drought with ArcherDX deal The cash-and-stock deal, worth $886m up front, is the first major liquid biopsy acquisition since Roche bought Foundation Medicine.